Senior Director - Executive Director, Hematology Oncology Drug Development

Incyte Corporation•Wilmington, DE

18h

About The Position

A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia. The Senior Director - Executive Medical Director, Drug Development is responsible for implementing clinical drug efforts for Incyte's oncology products (Phase I though Phase III).

Requirements

M.D. or D.O. degree with a minimum of 3-5 years of experience in oncology drug development in a biotechnology or pharmaceutical company.
Ability to multi-task and work in a dynamic environment.
Excellent written and verbal communication skills.

Nice To Haves

Board certified or eligible in Oncology preferred.

Responsibilities

Provides guidance for successful implementation and accomplishment of investigator-initiated trials related to product development and life cycle management of a compound.
Implements the highest ethical and regulatory standards during the investigation and development of anticancer agents.
Works in partnership with medical affairs for successful launch of future antineoplastic agents.
Detects and analyzes emergent issues during clinical drug development and develops and implements mitigating strategies.
Represents Incyte Corporation at key national and international medical and scientific meetings including participation in advisory boards with key opinion leaders.
Liaises with discovery science to facilitate and further the development of investigational agents from a preclinical stage to clinical development.
Serves as a source for medical and scientific expertise in oncology for outlining design strategy and execution for anti-cancer drug development.
Collaborates with external vendors such as CROs, external imaging and laboratory resources, as well as global pharmaceutical companies for successful implementation and conduct of early phase and registration global clinical studies.
Facilitates the development of key internal and external documents pertaining to product development including clinical study protocol, informed consents, CRFs, CSRs, meeting abstracts, scientific journal publications, strategy documents and project plans.
Interacts with global regulatory bodies including the FDA and EMA to accomplish tasks related to oncology product development and collaborates with internal regulatory experts and oversee the clinical research plans and sections for Investigational new Drug applications (INDs) and New Drug Applications (NDAs).
Provides medical and scientific expertise for internal cross-functional team members for development of specific anti-neoplastic agents including discovery scientists, medical scientists, biostatisticians, pharmacokineticists, pharmacovigilance and clinical operations.